Table 1.

Baseline characteristics and anthropometric profile in interventions and control groups

Variables	Mean±SD			P
	Diet group (n=35)	N-3 PUFA group (n=35)	Control group (n=34)
Age (years)	41.03±7.77	41.77±8.92	42.35±9.86	0.825*
Gender, n (%)
Male	19 (54.3)	18 (51.4)	20 (41.2)	0.753¶
Female	16 (45.7)	17 (48.6)	14 (41.2)
Smoking, n (%)
Smoker	3 (8.6)	4 (11.4)	5 (14.7)	0.720¶
Nonsmoker	32 (91.4)	31 (88.6)	29 (85.3)
Menopause status, n (%)
Premenopause	12 (75)	14 (82.4)	11 (78.6)	0.604¶
Postmenopause	4 (25)	3 (17.6)	3 (21.4)
Severity of fatty liver, n (%)
Mild	12 (34.3)	11 (31.4)	12 (35.3)	0.953¶
Moderate	15 (42.9)	15 (42.9)	13 (38.2)
Severe	8 (22.8)	9 (25.7)	9 (26.5)
Weight (kg)	87.38±12.55	85.19±10.54	84.75±11.22	0.728*
BMI (kg/m2)	31.65±3.91	31.48±3.56	30.65±3.36	0.483*
BMI category, n (%)
Overweight	15 (42.9)	14 (40.0)	15 (44.1)	0.982¶
Obesity class 1	14 (40.0)	16 (45.7)	15 (44.1)
Obesity class 2	6 (17.1)	5 (14.3)	4 (11.8)
PBF (%)	38.37±7.70	39.01±8.44	37.16±9.44	0.356**
FM (kg)	33.55±8.32	33.07±7.48	31.14±7.84	0.328*
FFM (kg)	53.83±10.20	52.12±10.63	53.61±12.35	0.433**
SMM (kg)	30.19±6.16	29.19±6.44	30.06±7.52	0.456**
Visceral fat area (cm2)	161.36±45.59	158.50±42.76	153.20±48.21	0.579*
WHR	0.997±0.063	0.985±0.045	0.997±0.064	0.713**
24-h MET-time (MET.h/d)	23.79±4.68	25.06±5.16	25.06±7.79	0.597*

Data are presented as mean±SD or percent of valid cases. *Analyzed by one-way ANOVA between three groups, **Analyzed by Kruskal-Wallis between three groups, ^¶P values for Chi-square test. BMI=Body mass index; PBF=Percent body fat; FM=Fat mass; FFM=Fat free mass; SMM=Skeletal muscle mass; WHR=Waist-hip ratio; MET=Metabolic equivalent of task; N-3 PUFA=n-3 polyunsaturated fatty acid; SD=Standard deviation